Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NOVOVISION PTE. LTD.
Singapore, Singaporenovomatic.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
NOVOVISION PTE. LTD. was incorporated in October 2024 and positions itself as an AI-driven pharmaceutical innovator targeting metabolic diseases, autoimmune disorders, and solid tumors. The company seeks collaborations with pharma/biotech partners to develop its pipeline but has not disclosed specific clinical results or programs yet.
- Therapeutic areas
- ImmunologyMetabolic DisordersOncology
- Modalities
- small moleculesbiologics
- Industry
- Biotech
02
Partnerships
Seeking partnerships with pharma/biotech companies for joint development; none specifically named yet.
Beyond the preview
Go deeper on NOVOVISION PTE. LTD..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NOVOVISION PTE. LTD..